Telomir Pharmaceuticals, Inc.
TELO • NASDAQ
Telomir Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Erez Aminov, with a market cap of $43.0M.
CEOErez Aminov
Next Earnings
Upcoming earnings announcement for Telomir Pharmaceuticals, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.07
Earnings History
Past 8 earnings reports for Telomir Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.06Est: -$0.07 | +14.3% | - | — | — |
| Nov 10, 2025 | Q3 2025 | -$0.03Est: -$0.07 | +57.1% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.17Est: -$0.08 | -112.5% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.07Est: -$0.10 | +30.0% | - | — | 10-Q |
| Feb 4, 2025 | Q4 2024 | -$0.08 | — | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.20 | — | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.05 | — | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.23 | — | - | — | 10-Q |